Besides the above-described role of NF-κB as a promoter of abnormal cancer cell division and survival, it could contribute to melanoma progression through the activation of immune checkpoints, such that it is considered a molecular target in immunotherapy approaches. Here, NFKB1 is linked to melanoma.